header logo image


Page 16«..10..15161718..3040..»

Archive for the ‘Immune System’ Category

Dr Todd Rice Explains the Anti-inflammatory Benefits of Vitamin D to Our Immune Systems – AJMC.com Managed Markets Network

Sunday, October 25th, 2020

We are still working to figure out why low levels of vitamin D are associated with worse outcomes in critical illness, noted Todd W. Rice, MD, FCCP, associate professor of medicine at Vanderbilt University Medical Center in Nashville, Tennessee.

Studies have shown that low levels of vitamin D are associated with worse outcomes in critical illnessfor instance, needing to be in the intensive care unit (ICU) morebut we are still working to figure out why, noted Todd W. Rice, MD, FCCP, associate professor of medicine at Vanderbilt University Medical Center in Nashville, Tennessee, in an interview for this years CHEST Annual Meeting.

Transcript

Tell us about your presentation on day 1 of CHEST, Vitamin D in Critical Illness: Helpful Fact or Hopeless Fiction.

This is a presentation in a session about vitamins and vitamins in the ICU. And obviously, based off of the title, Im going to talk about vitamin D. The short, brief story of vitamin D is that weve had a number of studies that have shown that low levels of vitamin D are associated with worse outcomes, including needing to be into the ICU more, having more infections in the ICU, and staying in the ICU longer, having higher mortality while youre in the ICU. And so the thought process is that repleting peoples vitamin D to normal levels may prevent some of these bad outcomes. And weve tried this in a number of trials and we havent had great success in improving outcomes by giving patients vitamin D. And the question then becomes, why is that the case? Is it that low vitamin D level is not the reason that people do worse, its just kind of associated with being sick and doing worse? Or is there something about vitamin D metabolism and vitamin D absorption that we dont yet understand? So were not really supplementing it right, were not really targeting the right levels, those sorts of things. And I think were still working to figure that out.

How do the pleiotropic effects of micronutrients affect critical illness?

Vitamin D has a number of kind of positive effects in the body. Obviously, its involved in bone metabolismthats probably not that relevant in critical illnessbut its very, very, very much involved in the immune system. And its sort of a cofactor for our immune cells in fighting infection. And its been shown in a number of other studies, not in the ICU, that low vitamin D levels result in less robust immune systems, more prone to get infections, and worse outcomes.

The other effects of it are that it seems to have some anti-inflammatory effects. We dont entirely understand exactly how it decreases inflammation, but it seems to decrease inflammation and also kind of has some effects on the endothelial lining of the lungs and the vasculature. So all of those effects kind of together are pleiotropic in the fact that they sort of grow these areas, stimulate these areas, and are beneficial to the body in that regard.

Read more:
Dr Todd Rice Explains the Anti-inflammatory Benefits of Vitamin D to Our Immune Systems - AJMC.com Managed Markets Network

Read More...

Will masks become the ‘new normal’ even after the pandemic has passed? Some Americans say so – CNBC

Sunday, October 25th, 2020

People wear face masks in Times Square as the city continues the re-opening efforts following restrictions imposed to slow the spread of coronavirus on October 22, 2020 in New York City.

Noam Galai | Getty Images

Mandy Elmore, 47, has been wearing masks for more than 20 years. That's because she has cystic fibrosis, a hereditary disease that affects her lungs and digestive system.

Because of her illness, a cold or flu can land her in the hospital. Prior to the pandemic, Elmore, who lives in Dallas, Texas, had to stop going to church or traveling on planes to avoid strangers coughing and sneezing directly on her.

"Masks offer freedom for those of us who are sick," she said. "I would feel comfortable going to church in the winter or to movies or to birthday parties if people could think about those like me who truly suffer as a result of a simple cold virus."

For millions of Americans like Elmore, it would change their lives for the better if it became more of a cultural norm in the U.S. for people to wear masks when they're under the weather or in crowded areas. The West has stigmatized mask-wearing, but in countries like Japan or South Korea, residents might get dirty looks if they hop on a subway with a sniffle and no mask.

Still, there's reason for skepticism. Not everyone in America is wearing masks, even now, when public health officials are strongly encouraging them to do so. Rallies to protest masks have popped up across the country, with many Americans pointing out that it's a violation of their personal freedoms.

But for others, who potentially represent a less vocal majority, it could become the new normal. Since the start of the pandemic, many people bought a handful of masks for the first time and have gotten used to wearing them in public. Doctors and public health experts believe that American culture could fundamentally shift to embrace new hygiene practices.

"I think we do need a new culture of masks, at least any time not feeling well, and I think masks are in and handshakes out for the indefinite future," said Dr. Tom Frieden, the former director of the C.D.C. during the Obama Administration and the president of global health initiative Resolve to Save Lives.

"Post pandemic, there will be new social norms," added Dr. Panagis Galiatsatos, a pulmonary and critical care doctor, who treats patients with chronic respiratory conditions like COPD and cystic fibrosis, as well as Covid-19.

"I think face masks will continue to be used by the general public in times when they don't feel well, and honestly we're realizing that no one feels slighted without a handshake," he said.

Sometimes, it takes a pandemic to change behavior. Across East Asia, mask wearing really took off in the aftermath of the SARS outbreak in 2003. The U.S. was largely spared from SARS. But in Hong Kong, where more than 280 people died, there was widespread panic. All of that led to many countries developing practices around how to tamp down on potential disease outbreaks early, with measures like social distancing, travel bans, and masks.

Almost two decades later, this advanced planning gave the region an edge when it came to Covid-19. Many people already had a mask or two at home and had become used to wearing one. In countries like Taiwan, those who did not wear a mask were occasionally even publicly shamed on social media for failing to take proper precautions.

William Hsiao, emeritus professor of economics inthe Department of Health Policy and Management at the Harvard T.H. Chan School of Public Health, told CNBC that in these cultures, there's a strong feeling that sometimes people have to sacrifice their "individual desires and benefits" for the sake of their community. That helped countries like Taiwan and Vietnam, which have experienced relatively few cases of Covid-19, come together to face a threat in a more unified way. In Taiwan, only 7 people have died from the virus, while Vietnam has reported just 35 deaths.

In the West, it hasn't been as easy to disseminate public health measures. Not all Americans have eagerly embraced mask-wearing, even in the height of the pandemic. Research organizations like Brookings say that "a culture of individualism" is an obstacle. Americans aren't as used to putting the needs of the community ahead of themselves.

Still, some Americans say their perspective has fundamentally shifted. Rather than powering through illness by going to school or work as normal, they say they'd take extra precautions or stay home. And some say that they'd be comfortable wearing a mask in a crowded setting from now on.

"I grew up going to school, even if I was sick" said Spencer Guthrie, 45, from San Francisco. "I never missed a single day of school from K-12."

But Guthrie said his views have changed since the start of the pandemic. He would take greater precautions now if he felt under the weather. "Masks are not the slightest bit inconvenient for long periods of time if you find one that fits well," he said.

Others say they discovered unexpected benefits to wearing a mask. Hope King, a New York-based journalist, has found comfort in that moment on the street when people pull their mask up as they approach. She sees it as a sign of respect.

King has experienced the rise of anti-Asian racism during the pandemic. So wearing a mask makes her feel safer.

"I think maybe you can't tell immediately that I'm Asian from far away, especially if I'm wearing glasses," she said.

King envisions keeping her mask on as long as people around her continue to do so. She also plans to wear one if she starts to feel sick, as a signal to others that she's invested in protecting them.

For some young Americans, wearing a mask just isn't big deal. Gurdane Bhutani, 29, suspects that face coverings won't be perceived as a "strange thing to do" in the future at times when people are packed together. He already refrains from eating peanuts on an airplane in case someone has an allergy. So a mask doesn't seem any different.

"It's not hard to do, and it could make a difference for someone else," he said. "I know people with autoimmune conditions are feeling really relieved that everyone is wearing masks now."

Doctors like Krishna Komanduri, chief of the division of transplantation and cellular therapy at the University of Miami, has noticed an increased empathy for immunocompromised patients in recent months. People with weakened immune systems have long feared getting sick and that prospect is never far from their thoughts.

And now, with Covid-19, even young and healthy people are concerned about avoiding germs and spreading illness.

"For our cancer patients, nothing has really changed," he said. "Rather we have been drawn into their world."

Cancer patients, he said, or really anyone with a compromised immune system, are no strangers to masks and social distancing. Some received strange looks prior to the pandemic, he said. But not anymore. "More widespread adoption of these measures would be good in general," he explained.

For her part, Elmore, who suffers from cystic fibrosis, has never felt safer. And ironically, that's during a respiratory pandemic.

"Now, if someone coughs or sneezes with a mask on in the store, I'm not trying to run to get away," she said. "Pre-Covid, I would literally breathe out and walk as fast as possible to get away from the airflow."

Elmore said her entire family would keep their ears alerted for any hint of sickness at a time when very few people wore masks. "My husband used to say, 'cougher on the left,' to prevent me from breathing as they walked by," she said.

Elmore isn't expecting that everyone will wear masks at all times in the future. She is hoping that people will take more precautions, however, when they start feeling sick. "I do hope those that are having symptoms will consider them," she said.

Read the rest here:
Will masks become the 'new normal' even after the pandemic has passed? Some Americans say so - CNBC

Read More...

MSK-led Studies Support the Concept of Cancer Environment Immunotherapy – On Cancer – Memorial Sloan Kettering

Sunday, October 25th, 2020

Summary

Two MSK-led studies published in the journal Nature support the idea of using immunotherapy drugs to treat the environment surrounding a tumor as an indirect way to combat cancer.

Despite the remarkable successes of immune-based treatments for cancer, not everyone responds to these approaches, and relapses do occur. Researchers around the world are racing to find ways to improve outcomes for people receiving immunotherapy. But new findings from scientists at Memorial Sloan Kettering suggest they may be focusing too narrowly on the problem.

According to Ming Li, an immunologist in the Sloan Kettering Institute, most existing immunotherapy approaches, including both checkpoint blockade and CAR T therapy, aim to prod the immune system into finding and killing cancer cells a kind of frontal attack on the disease.

But tumors also need supportive environments safe harbors in which to grow and thrive. They need the support of blood vessels that provide them with nutrients, Dr. Li says.

Could destroying these safe harbors be an indirect way to fight this internal enemy? Dr. Li thinks the answer is yes, and on October 21, he published two papers in the journal Nature in support of the concept.

We know that the immune system is incredibly adept at recognizing harmful invaders and attacking them with precision, he says. But thats not the only way our immune system protects us from threats. It also promotes healing of damaged tissue so that pathogens cant take root in the body. This latter role, we now show, can also be enlisted in the fight against cancer.

Dr. Li and his colleagues found they could thwart cancers in mice by encouraging immune cells to begin the process of wound repair around a tumor. In the process, blood vessels that feed the cancer are pruned away and cancer cells starve and die. Its an approach that Dr. Li has dubbed cancer environment immunotherapy.

To understand how wound healing can help curb cancer, consider what happens when someone gets an injury, say a cut from a knife. Early on, the site becomes inflamed red, hot, and swollen. During this phase of wound healing, blood vessels dilate and immune cells rush in to fight enemies that may cause infection and clean up the debris. But later on, the wound fills in with new tissue, and inflammation resolves.

An important player in the wound healing process is a molecule called TGF-beta, whose presence waxes and wanes with the inflammation cycle. In the context of a cancerous wound, TGF-beta persists and makes cancer growth worse. By contrast, blocking its action inhibits tumor development. This latter effect is dependent upon immune cells called T cells, previous research has shown.

Blocking the action of a molecule called TGF-beta in immune cells (right) triggers cell death (blue) in tumors in mice.

Dr. Li and his team wanted to find out more about which T cells were involved in curbing cancer growth when TGF-beta is blocked. They initially suspected that a subset of T cells called CD8 T cells, or killer T cells, were responsible for restraining tumor development. But when they genetically removed the receptor for TGF-beta from CD8 cells in mice, it had no effect on cancer growth.

Next, they asked whether a different subset of T cells, called CD4 T cells, or helper T cells, could explain the phenomenon of cancer suppression. Indeed, genetically removing the receptor for TGF-beta in CD4 T cells dramatically reduced cancer growth in mice.

How do CD4 T cells contribute to cancer control in this context? Dr. Li and his colleagues found that these cells promote wound healing around a tumor. As part of this process, the blood vessels supplying nutrients to a tumor are dramatically remodeled, and a kind of protective wall is formed around the tumor, depriving it of sustenance.

These results, reported in the first Nature paper, showed that blocking TGF-beta signaling in CD4 T cells could activate a powerful wound healing response that directly opposes cancer development.

But what about tumors that have already been growing? Could blocking TGF-beta restrain them? Dr. Li and his team explored this question in a second set of experiments, published in a second Nature article.

By blocking TGF-beta inhelper T cells, we allow the wound healing to run to completion. We heal the wound that is cancer.

They designed an antibody-based drug that can bind to both TGF-beta andhelper T cells. They found that this drug, which they called 4T-Trap, could dramatically reduce cancer in mice.

Previous attempts at blocking TGF-beta as a cancer treatment have not been successful, likely because this molecule has many effects in the body, and therefore blocking it completely can cause severe side effects such as heart problems or even the appearance of new cancers. But 4T-Trap targets the TGF-beta-blocking-molecule directly to CD4 T cells, so side effects are reduced. In other words, its a more targeted approach.

That fact that CD4helper T cells were the key players rather than CD8 killer T cells came as something of a surprise to the researchers. These days, CD8 cytotoxic T cells that recognize cancer cells are in the spotlight. Dr. Li says, Its almost become dogma that if its T cell mediated, then it must be CD8 T cells. That was our original hypothesis, too. But that turns out not to be the case.

Yet the findings are not completely unprecedented. In fact, the discovery that the promotion of wound healing can dramatically curb cancer progression meshes nicely with older work. In the mid-1980s, cancer researcher Harold Dvorak published a now-famous article in the New England Journal of Medicine, in which he argued that tumors are essentially wounds that do not heal. Tumors enlist normal wound healing to help themselves grow. They thrive by enlisting the early stages of the immune responses to tissue damage growth of new blood vessels, for example but then never get to later stages of wound healing when these blood vessels are normally pruned away.

By blocking TGF-beta inhelper T cells, we allow the wound healing to run to completion, Dr. Li says. We heal the wound that is cancer.

Reflecting on the way his results echo these earlier findings, Dr. Li says, Its an exciting homecoming.

He proposes that such cancer environment immunotherapy could be a powerful addition to current immune-based treatments for cancer. His lab is currently collaborating with physician-researchers at MSK to translate these new findings to patients.

Original post:
MSK-led Studies Support the Concept of Cancer Environment Immunotherapy - On Cancer - Memorial Sloan Kettering

Read More...

What We Know So Far about How COVID Affects the Nervous System – Scientific American

Sunday, October 25th, 2020

Many of the symptoms experienced by people infected with SARS-CoV-2 involve the nervous system. Patients complain of headaches, muscle and joint pain, fatigue and brain fog, or loss of taste and smellall of which can last from weeks to months after infection. In severe cases, COVID-19 can also lead to encephalitis or stroke. The virus has undeniable neurological effects. But the way it actually affects nerve cells still remains a bit of a mystery. Can immune system activation alone produce symptoms? Or does the novel coronavirus directly attack the nervous system?

Some studiesincluding a recent preprint paper examining mouse and human brain tissueshow evidence that SARS-CoV-2 can get into nerve cells and the brain. The question remains as to whether it does so routinely or only in the most severe cases. Once the immune system kicks into overdrive, the effects can be far-ranging, even leading immune cells to invade the brain, where they can wreak havoc.

Some neurological symptoms are far less serious yet seem, if anything, more perplexing. One symptomor set of symptomsthat illustrates this puzzle and has gained increasing attention is an imprecise diagnosis called brain fog. Even after their main symptoms have abated, it is not uncommon for COVID-19 patients to experience memory loss, confusion and other mental fuzziness. What underlies these experiences is still unclear, although they may also stem from the body-wide inflammation that can go along with COVID-19. Many people, however, develop fatigue and brain fog that lasts for months even after a mild case that does not spur the immune system to rage out of control.

Another widespread symptom called anosmia, or loss of smell, might also originate from changes that happen without nerves themselves getting infected. Olfactory neurons, the cells that transmit odors to the brain, lack the primary docking site, or receptor, for SARS-CoV-2, and they do not seem to get infected. Researchers are still investigating how loss of smell might result from an interaction between the virus and another receptor on the olfactory neurons or from its contact with nonnerve cells that line the nose.

Experts say the virus need not make it inside neurons to cause some of the mysterious neurological symptoms now emerging from the disease. Many pain-related effects could arise from an attack on sensory neurons, the nerves that extend from the spinal cord throughout the body to gather information from the external environment or internal bodily processes. Researchers are now making headway in understanding how SARS-CoV-2 could hijack pain-sensing neurons, called nociceptors, to produce some of COVID-19s hallmark symptoms.

Neuroscientist Theodore Price, who studies pain at the University of Texas at Dallas, took note of the symptoms reported in the early literature and cited by patients of his wife, a nurse practitioner who sees people with COVID remotely. Those symptoms include sore throat, headaches, body-wide muscle pain and severe cough. (The cough is triggered in part by sensory nerve cells in the lungs.)

Curiously, some patients report a loss of a particular sensation called chemethesis, which leaves them unable to detect hot chilies or cool peppermintsperceptions conveyed by nociceptors, not taste cells. While many of these effects are typical of viral infections, the prevalence and persistence of these pain-related symptomsand their presence in even mild cases of COVID-19suggest that sensory neurons might be affected beyond normal inflammatory responses to infection. That means the effects may be directly tied to the virus itself. Its just striking, Price says. The affected patients all have headaches, and some of them seem to have pain problems that sound like neuropathies, chronic pain that arises from nerve damage. That observation led him to investigate whether the novel coronavirus could infect nociceptors.

The main criteria scientists use to determine whether SARS-CoV-2 can infect cells throughout the body is the presence of angiotensin-converting enzyme 2 (ACE2), a protein embedded in the surface of cells. ACE2 acts as a receptor that sends signals into the cell to regulate blood pressure and is also an entry point for SARS-CoV-2. So Price went looking for it in human neurons in a study now published in the journal PAIN.

Nociceptorsand other sensory neuronslive in discreet clusters, found just outside the spinal cord, called dorsal root ganglia (DRG). Price and his team procured nerve cells donated after death or cancer surgeries. The researchers performed RNA sequencing, a technique to determine which proteins a cell is about to produce, and they used antibodies to target ACE2 itself. They found that a subset of DRG neurons did contain ACE2, providing the virus a portal into the cells.

Sensory neurons send out long tendrils called axons, whose endings sense specific stimuli in the body and then transmit them to the brain in the form of electrochemical signals. The particular DRG neurons that contained ACE2 also had the genetic instructions, the mRNA, for a sensory protein called MRGPRD. That protein marks the cells as a subset of neurons whose endings are concentrated at the bodys surfacesthe skin and inner organs, including the lungswhere they would be poised to pick up the virus.

Price says nerve infection could contribute to acute, as well as lasting, symptoms of COVID. The most likely scenario would be that the autonomic and sensory nerves are affected by the virus, he says. We know that if sensory neurons get infected with a virus, it can have long-term consequences, even if the virus does not stay in cells.

But, Price adds, it does not need to be that the neurons get infected. In another recent study, he compared genetic sequencing data from lung cells of COVID patients and healthy controls and looked for interactions with healthy human DRG neurons. Price says his team found a lot of immune-system-signaling molecules called cytokines from the infected patients that could interact with receptors on neurons. Its basically a bunch of stuff we know is involved in neuropathic pain. That observation suggests that nerves could be undergoing lasting damage from the immune molecules without being directly infected by the virus.

Anne Louise Oaklander, a neurologist at Massachusetts General Hospital, who wrote a commentary accompanying Prices paper in PAIN, says that the study was exceptionally good, in part because it used human cells. But, she adds, we dont have evidence that direct entry of the virus into [nerve] cells is the major mechanism of cellular [nerve] damage, though the new findings do not discount that possibility. It is absolutely possible that inflammatory conditions outside nerve cells could alter their activity or even cause permanent damage, Oaklander says. Another prospect is that viral particles interacting with neurons could lead to an autoimmune attack on nerves.

ACE2 is widely thought to be the novel coronaviruss primary entry point. But Rajesh Khanna, a neuroscientist and pain researcher at the University of Arizona, observes that ACE2 is not the only game in town for SARS-CoV-2 to come into cells. Another protein, called neuropilin-1 (NRP1), could be an alternate doorway for viral entry, he adds. NRP1 plays an important role in angiogenesis (the formation of new blood vessels) and in growing neurons long axons.

That idea came from studies in cells and in mice. It was found that NRP1 interacts with the viruss infamous spike protein, which it uses to gain entry into cells. We proved that it binds neuropilin and that the receptor has infectious potential, says virologist Giuseppe Balistreri of the University of Helsinki, who co-authored the mouse study, which was published in Sciencealong with a separate study in cells. It appears more likely that NRP1 acts as a co-factor with ACE2 than that the protein alone affords the virus entry to cells. What we know is that when we have the two receptors, we get more infection. Together, its much more powerful, Balistreri adds.

Those findings piqued the interest of Khanna, who was studying vascular endothelial growth factor (VEGF), a molecule with a long-recognized role in pain signaling that also binds to NRP1. He wondered whether the virus would affect pain signaling through NRP1, so he tested it in rats in a study that was also published in PAIN. We put VEGF in the animal [in the paw], and lo and behold, we saw robust pain over the course of 24 hours, Khanna says. Then came the really cool experiment: We put in VEGF and spike at the same time, and guess what? The pain is gone.

The study showed what happens to the neurons signaling when the virus tickles the NRP1 receptor, Balistreri says. The results are strong, demonstrating that neurons activity was altered by the touch of the spike of the virus through NRP1.

In an experiment in rats with a nerve injury to model chronic pain, administering the spike protein alone attenuated the animals pain behaviors. That finding hints that a spike-like drug that binds NRP1 might have potential as a new pain reliever. Such molecules are already in development for use in cancer.

In a more provocative and untested hypothesis, Khanna speculates that the spike protein might act at NRP1 to silence nociceptors in people, perhaps masking pain-related symptoms very early in an infection. The idea is that the protein could provide an anesthetic effect as SARS-CoV-2 begins to infect a person, which might allow the virus to spread more easily. I cannot exclude it, says Balistreri. Its not impossible. Viruses have an arsenal of tools to go unseen. This is the best thing they know: to silence our defenses.

It still remains to be determined whether a SARS-CoV-2 infection could produce analgesia in people. They used a high dose of a piece of the virus in a lab system and a rat, not a human, Balistreri says. The magnitude of the effects theyre seeing [may be due to] the large amount of viral protein they used. The question will be to see if the virus itself can [blunt pain] in people.

The experience of one patientRave Pretorius, a 49-year-old South African mansuggests that continuing this line of research is probably worthwhile. A motor accident in 2011 left Pretorius with several fractured vertebrae in his neck and extensive nerve damage. He says he lives with constant burning pain in his legs that wakes him up nightly at 3 or 4 A.M. It feels like somebody is continuously pouring hot water over my legs, Pretorius says. But that changed dramatically when he contracted COVID-19 in July at his job at a manufacturing company. I found it very strange: When I was sick with COVID, the pain was bearable. At some points, it felt like the pain was gone. I just couldnt believe it, he says. Pretorius was able to sleep through the night for the first time since his accident. I lived a better life when I was sick because the pain was gone, despite having fatigue and debilitating headaches, he says. Now that Pretorius has recovered from COVID, his neuropathic pain has returned.

For better or worse, COVID-19 seems to have effects on the nervous system. Whether they include infection of nerves is still unknown like so much about SARS-CoV-2. The bottom line is that while the virus apparently can, in principle, infect some neurons, it doesnt need to. It can cause plenty of havoc from the outside these cells.

Read more about the coronavirus outbreak from Scientific American here. And read coverage from our international network of magazines here.

Follow this link:
What We Know So Far about How COVID Affects the Nervous System - Scientific American

Read More...

Protein that Keeps Immune System from Freaking Out Could Form Basis for New Therapeutics – UC San Diego Health

Sunday, October 18th, 2020

The immune response to infections is a delicate balance. We need just enough action to clear away the offending bacteria or viruses, but not so much that our own bodies suffer collateral damage.

Macrophages are immune cells at the front line, detecting pathogens and kicking off an inflammatory response when needed. Understanding how macrophages determine when to go all-out and when to keep calm is key to finding new ways to strike the right balance particularly in cases where inflammation goes too far, such as in sepsis, colitis and other autoimmune disorders.

Two macrophages (blue) fighting to engulf the same pathogen (green). GIV/Girdin is shown in red.

In a study published October 14, 2020 in the Proceedings of the National Academy of Sciences, researchers at University of California San Diego School of Medicine discovered that a molecule called Girdin, or GIV, acts as a brake on macrophages.

When the team deleted the GIV gene from mouse macrophages, the immune cells rapidly overacted to even small amounts of live bacteria or a bacterial toxin. Mice with colitis and sepsis fared worse when lacking the GIV gene in their macrophages.

The researchers also created peptides that mimic GIV, allowing them to shut down mouse macrophages on command. When treated with the GIV-mimic peptide, the mices inflammatory response was tempered.

When a patient dies of sepsis, he or she does not die due to the invading bacteria themselves, but from an overreaction of their immune system to the bacteria, said senior author Pradipta Ghosh, MD, professor at UC San Diego School of Medicine and Moores Cancer Center. Its similar to what were seeing now with dangerous cytokine storms that can result from infection with the novel coronavirus SARS-CoV-2. Macrophages, and the cytokines they produce, are the bodys own immune-stimulating agents and when produced in excessive amounts, they do more harm than good.

Digging deeper into the mechanism at play, Ghosh and team discovered that the GIV protein normally cozies up to a molecule called Toll-like receptor 4 (TLR4). TLR4 is stuck right through the cell membrane, with bits poking inside and outside the cell. Outside of the cell, TLR4 is like an antenna, searching for signs of invading pathogens. Inside the cell, GIV is nestled between the receptors two feet. When in place, GIV keeps the feet apart, and nothing happens. When GIV is removed, the TLR4 feet touch and kick off a cascade of immune-stimulating signals.

Ghoshs GIV-mimicking peptides can take the place of the protein when its missing, keeping the feet apart and calming macrophages down.

We were surprised at just how fluid the immune system is when it encounters a pathogen, said Ghosh, who is also director of the Institute for Network Medicine and executive director of the HUMANOID Center of Research Excellence at UC San Diego School of Medicine. Macrophages dont need to waste time and energy producing more or less GIV protein, they can rapidly dial their response up or down simply by moving it around, and it appears that such regulation happens at the level of gene transcription.

Ghosh and team plan to investigate the factors that determine how the GIV brake remains in place when macrophages are resting or is removed to mount a response to a credible threat. To enable these studies, the Institute for Network Medicine at UC San Diego School of Medicine recently received a new $5 million grant from the National Institute of Allergy and Infectious Diseases, part of the National Institutes of Health. Ghosh shares this award with her colleagues Debashis Sahoo, PhD, assistant professor at UC San Diego School of Medicine and Jacobs School of Engineering, and Soumita Das, PhD, associate professor of pathology at UC San Diego School of Medicine.

Co-authors of the study include: Lee Swanson, Gajanan D. Katkar, Julian Tam, Rama F. Pranadinata, Yogitha Chareddy, Jane Coates, Mahitha Shree Anandachar, Vanessa Castillo, Joshua Olson, Victor Nizet, Irina Kufareva, Soumita Das, all at UC San Diego.

Funding for this research came, in part, from the National Institutes for Health (grants AI141630, AI155696, CA100768, CA160911, DK107585, UL1TR001442, DK 0070202), DiaComp and Helmsley Charitable Trust.

Read the original post:
Protein that Keeps Immune System from Freaking Out Could Form Basis for New Therapeutics - UC San Diego Health

Read More...

What We Know And Don’t Know About COVID-19 Reinfection Cases – ScienceAlert

Sunday, October 18th, 2020

As President Trump claims that he is immune to COVID-19 and isolated reports emerge of reinfection, what is the truth about immunity to COVID-19?

To date, there have been six published cases of COVID-19 reinfection, with various other unverified accounts from around the world. Although this is a comparably small fraction of the millions of people known to have been infected, should we be concerned? To unpick this puzzle, we must first consider what we mean by immunity.

When we are infected with any pathogen, our immune system quickly responds to try to contain the threat and minimise any damage. Our first line of defence is from immune cells, known as innate cells. These cells are not usually enough to eliminate a threat, which is where having a more flexible "adaptive" immune response comes into play our lymphocytes.

Lymphocytes come in two main varieties: B lymphocytes, which make antibodies, and T lymphocytes, which include cells that directly kill the germy invaders.

As antibodies are readily measured in blood, they are often used to indicate a good adaptive immune response. However, over time, antibodies levels in our blood wane, but this doesn't necessarily mean protection is lost. We retain some lymphocytes that know how to deal with the threat our memory cells. Memory cells are remarkably long-lived, patrolling our body, ready to spring into action when needed.

Vaccines work by creating memory cells without the risk of a potentially fatal infection. In an ideal world, it would be relatively easy to create immunity, but it's not always that straightforward.

Although our immune system has evolved to deal with a huge variety of pathogens, these germs have also evolved to hide from the immune system. This arms race means that some pathogens such as malaria or HIV are very tricky to deal with.

Infections that have spilled over from animals - zoonotic diseases - are also challenging for our immune system because they can be completely novel. The virus that causes COVID-19 is such a zoonotic disease, originating in bats.

COVID-19 is caused by a betacoronavirus. Several betacoronaviruses are already common in the human population most familiar as a cause of the common cold. Immunity to these cold-causing viruses isn't that robust but immunity to the more serious conditions, Mers and Sars, is more durable.

Data to date on COVID-19 shows that antibodies can be detected three months after infection, although, as with Sars and Mers, antibodies gradually decrease over time.

Of course, antibody levels are not the only indication of immunity and don't tell us about T lymphocytes or our memory cells. The virus causing COVID-19 is structurally similar to Sars, so perhaps we can be more optimistic about a more durable protective response time will tell. So how worried then should we be about reports of reinfection with COVID-19?

The handful of case reports on reinfection with COVID-19 don't necessarily mean that immunity is not occurring. Issues with testing could account for some reports because "virus" can be detected after infection and recovery. The tests look for viral RNA (the virus's genetic material), and viral RNA that cannot cause infection can be shed from the body even after the person has recovered.

Conversely, false-negative results happen when the sample used in testing contains insufficient viral material to be detected for example, because the virus is at a very low level in the body. Such apparent negative results may account for cases in which the interval between the first and second infection is short. It is hugely important, therefore, to use additional measures, such as viral sequencing and immune indicators.

Reinfection, even in immunity, can happen, but usually this would be mild or asymptomatic because the immune response protects against the worst effects. Consistent with this is that most verified cases of reinfection reported either no or mild symptoms. However, one of the latest verified cases of reinfection which happened just 48 days after the initial infection actually had a more severe response to reinfection.

What might account for the worse symptoms the second time round? One possibility is the patient did not mount a robust adaptive immune response first time round and that their initial infection was largely contained by the innate immune response (the first line of defence). One way to monitor this would be to assess the antibody response as the type of antibody detected can tell us something about the timing of infection. But unfortunately, antibody results were not analysed in the recent patient's first infection.

Another explanation is that different viral strains caused the infections with a subsequent impact on immunity. Genetic sequencing did show differences in viral strains, but it isn't known if this equated to altered immune recognition. Many viruses share structural features, enabling immune responses to one virus to protect against a similar virus. This has been suggested to account for the lack of symptoms in young children who frequently get colds caused by betacoronaviruses.

However, a recent study, yet to be peer-reviewed, found that protection against cold-causing coronaviruses did not protect against COVID-19. In fact, antibodies recognising similar viruses can be dangerous accounting for the rare phenomenon of antibody-dependent enhancement of disease (ADE). ADE occurs when antibodies enhance viral infection of cells with potentially life-threatening consequences.

It should be emphasised, though, that antibodies are only one indicator of immunity and we have no data on either T lymphocytes or memory cells in these cases. What these cases emphasise is a need to standardised approaches in order to capture the critical information for robust evaluation of the threat of reinfection.

We are still learning about the immune response to COVID-19, and every piece of new data is helping us unpick the puzzle of this challenging virus. Our immune system is a powerful ally in the fight against infection, and only by unlocking it can we ultimately hope to defeat COVID-19.

Sheena Cruickshank, Professor in Biomedical Sciences, University of Manchester.

This article was originally published byThe Conversation. Read the original article.

See original here:
What We Know And Don't Know About COVID-19 Reinfection Cases - ScienceAlert

Read More...

Boost your immune system with THESE 5 healthy juice recipes shared by Nutritionist Arooshi Agarwal – PINKVILLA

Sunday, October 18th, 2020

Having healthy juices is an easy and effective way to enhance your immunity to combat all diseases and infections. Here are 5 juice recipes from Arooshi Agarwal, Nutritionist and founder of Arooshis Nutrylife to amp up your immune system.

Our immune system works constantly without a pause and so it requires the best fuel for its performance in figuring out which cells belong to our body and which doesnt. These internal little wonderful warriors (antibodies) that protect us from diseases, infections, and what not needs ultimate care so that we are kept healthy and strong from inside. The immune system doesnt only need the right conditions to perform but also requires the right nutrition.

The current global crisis has made us realize the importance of immunity in our daily lives. Good immunity wont come easy without taking care of the gut (small intestine) and liver health. More than 70% of our immune system is in our gut which forms a foundation of our overall health. These two are one of the most important organs in our body that ensures the immunity that we need in our daily life to combat all sorts of illnesses. Having different types of juice is one of the most effective ways to boost our immune system. Hence, Arooshi Aggarwal, nutritionist and founder of Arooshis Nutrylife, shares some easy juice recipes.

5 juice recipes shared by nutritionist Arooshi Agarwal.

Green Juice

Green juice is a powerhouse of supplements for a solid immune system. It works best for detoxifying the liver.You need Wheat Grass, bottle gourd, a handful of mint leaves, and lime. Do not add salt or any condiments, try taking it raw. Blend these green veggies. You can adjust the consistency either with water or coconut water. The ideal time to consume this juice is in the morning.This juice is packed with antioxidants, iron, potassium magnesium which have a nerve and muscle relaxing effect. This juice helps in reducing the inflammation, cools down the body heat and antioxidants help in building up the antibodies.

White Juice

For this juice, you will need bottle gourd, green apple, celery and ginger. Ginger has always been the go-to food for colds. This is because it kills rhinovirus, the infectious agent responsible for the common cold. Celery is filled with sodium, a natural electrolyte that helps to treat dehydration. Green apples are also rich in vitamin C that boosts our immunity. Blend these together with water and drink.

Orange juice

For orange juice, you will be needing carrots, pumpkin, and apricots. This juice is rich in Vitamin A which is also fat-soluble vitamin and helps us fight against eye infections and provides a better vision.

Red juice

For this refreshing juice, you will need beetroot, tomato, ginger, garlic, and turmeric. These are wonder veggies to improve immunity. These veggies keep gut flora (good bacteria) healthy and improve gut health. Not only this juice refreshes the mood but also helps to treat influenza, runny nose, and body aches. This juice is so healthy that it calms down the symptoms of Rheumatoid Arthritis as turmeric, garlic, and ginger have strong inflammatory effects.

Yellow juice

For this, you will need pineapple, carrot mint leaves and lemon. This juice is loaded with immunity builders. It helps in treating cold, cough, and sore throat. Pineapple can reduce the bronchial inflammation which provides better respiration and relieves from the excess mucus formation. This juice is high on Vitamin C, vitamin A, iron, potassium, and antioxidants which also benefit the skin and hair health.

Remember

These five juices will be a blessing to your immune system and vital organs. Also remember, hydration, exercise, and a healthy diet play a very important role to keep your immune system up. While juicing may benefit your physical health, it is equally important to take care of your mental health. A healthy mind resides in a healthy body and vice versa!

Also Read:Significance of self screening in early detection of Breast Cancer explained by Dr Chandrani Mallik

x Your comment has been submitted to the moderation queue

View post:
Boost your immune system with THESE 5 healthy juice recipes shared by Nutritionist Arooshi Agarwal - PINKVILLA

Read More...

Protein That Pumps the Brakes on Macrophages in Immune Overreaction – Genetic Engineering & Biotechnology News

Sunday, October 18th, 2020

At the front line of our immune system macrophages are standing by, detecting pathogens and kicking off an inflammatory response when needed. Understanding how these immune cells know when to go all-out and when to keep calm is critical to finding new ways to strike the right chord in cases where the immune system overreacts, such as in sepsis and other autoimmune disorders.

Researchers at the University of California (UC) San Diego School of Medicine report they have discovered a protein that acts as a brake on macrophages. Their findings, TLR4 signaling and macrophage inflammatory responses are dampened by GIV/Girdin, were published in the Proceedings of the National Academy of Sciences.

Sensing of pathogens by Toll-like receptor 4 (TLR4) induces an inflammatory response; controlled responses confer immunity but uncontrolled responses cause harm. Here we define how a multimodular scaffold, GIV, or Girdin, titrates such inflammatory response in macrophages, noted the researchers.

When the team deleted the GIV gene from mouse macrophages, the immune cells overreacted to small amounts of live bacteria. Mice with colitis and sepsis fared worse when lacking the GIV gene in their macrophages. They also created peptides that mimic GIV, which allowed them to put the brakes on mouse macrophages on command. When treated with the GIV-mimic peptide, the mices inflammatory response was tempered.

When a patient dies of sepsis, he or she does not die due to the invading bacteria themselves, but from an overreaction of their immune system to the bacteria, explained Pradipta Ghosh, MD, professor at UC San Diego School of Medicine and Moores Cancer Center. Its similar to what were seeing now with dangerous cytokine storms that can result from infection with the novel coronavirus SARS-CoV-2. Macrophages, and the cytokines they produce, are the bodys own immune-stimulating agents and when produced in excessive amounts, they do more harm than good.

Further observation revealed that the GIV protein works together with TLR4. Outside of the cell, TLR4 is like an antenna, searching for signs of invading pathogens. Inside the cell, GIV waits between the receptors two feet. When in place, GIV keeps the feet apart, and nothing happens. When GIV is removed, the TLR4 feet touch and sends off immune-stimulating signals.

We were surprised at just how fluid the immune system is when it encounters a pathogen, said Ghosh, who is also director of the Institute for Network Medicine and executive director of the HUMANOID Center of Research Excellence at UC San Diego School of Medicine. Macrophages dont need to waste time and energy producing more or less GIV protein, they can rapidly dial their response up or down simply by moving it around, and it appears that such regulation happens at the level of gene transcription.

The researchers are looking forward to investigating the factors that determine how the GIV brake remains in place when macrophages are resting or is removed to mount a response to a credible threat. The Institute for Network Medicine at UC San Diego School of Medicine recently received a $5 million grant from the National Institute of Allergy and Infectious Diseases, part of the National Institutes of Health. Ghosh shares this award with her colleagues Debashis Sahoo, PhD, assistant professor at UC San Diego School of Medicine and Jacobs School of Engineering, and Soumita Das, PhD, associate professor of pathology at UC San Diego School of Medicine.

Read the original:
Protein That Pumps the Brakes on Macrophages in Immune Overreaction - Genetic Engineering & Biotechnology News

Read More...

Why is coronavirus killing more men than women? – theday.com

Sunday, October 18th, 2020

Early in the coronavirus outbreak, hospital data from China revealed a startling disparity: COVID-19, the disease caused by the virus, was killing far more men than women.

That difference persisted in other Asian countries, such as South Korea, as well as in European countries, such as Italy. Then, it appeared in the United States.

By mid-October, the coronavirus had killed almost 17,000 more American men than women, according to data from the Centers for Disease Control and Prevention. For every 10 women claimed by the disease in the United States, 12 men have died, found an analysis by Global Health 50/50, a U.K.-based initiative to advance gender equality in health care.

That disparity was one of many alarming aspects of the new virus. It bewildered those unfamiliar with the role of gender in disease.

But the specialized group of researchers who study that relationship was not surprised. It prepared an array of hypotheses. One possible culprit was male behavior. Perhaps men were more likely to be exposed to the virus due to social factors; a disproportionately male workforce, for instance, could place more men in contact with infected people. Or men's lungs might be more vulnerable because they were more likely to smoke in the earliest countries to report the differences.

What has become more evident, 10 months into this outbreak, is that men show comparatively weaker immune responses to coronavirus infections, which may account for those added deaths.

"If you look at the data across the world, there are as many men as women that are infected. It's just the severity of disease that is stronger in most populations in men," Franck Mauvais-Jarvis, a Tulane University physician who studies gender differences in such diseases as diabetes. In such cases, biology can help explain why.

- The male immune response. Women generally have stronger immune systems, thanks to sex hormones, as well as chromosomes packed with immune-related genes. About 60 genes on the X chromosome are involved in immune function, Johns Hopkins University microbiologist Sabra Klein told The Washington Post in April. People with two X chromosomes can benefit from the double helping of some of those genes.

Akiko Iwasaki, who studies immune defenses against viruses at Yale University, wanted to see how sex differences might play out in coronavirus infections. She and her colleagues cast a proverbial net into the immune system to fish out schools of microscopic fighters.

"We did a holistic look at everything we can measure immunologically," Iwasaki said, listing a litany of the molecules and cells that form the body's bulwark against pathogens: "cytokines, chemokines, T cells, B cells, neutrophils. Everything that we had access to."

In male patients, the T-cell response was weaker, the scientists found. Not only do T cells detect infected cells and kill them, they also help direct the antibody response. "It's like a master regulator of immune response. And when you have a drop in T cells, or in their ability to become activated, you basically lose the conductor of an orchestra," Iwasaki said.

The power of the immune system wanes as people age, regardless of sex. But what is a gentle decline for women is an abrupt dive off a cliff for men: Iwasaki's work indicates the T-cell response of men in their 30s and 40s is equivalent to that of a woman in her 90s.

And T cells aren't the only immune feature disproportionately impaired in men. Another paper, published in September in PLOS Biology, examined anonymous human genetic material collected along with viruses in nasal swabs.

That study found throttled defense signals in men. When a cell detects a virus, it performs the molecular equivalent of yanking the fire alarm, said one of the study's author, Nicole Lieberman, a research scientist at the University of Washington. That alarm is manifest in genetic messengers, called RNA, which react almost immediately.

The reaction should cause cells to churn out the first lines of defense, such as interferons, immune system molecules that, as the name suggests, interfere with the virus's ability to reproduce. Other molecules summon specialized immune cells to destroy the pathogens. "You want the fire alarm to go off for long enough that you can get the fire department there," Lieberman said.

Lieberman and her co-authors, however, found that in men and some older populations, the fire alarm shuts off early - maybe even before the firefighters have arrived. "That, I think, is the functional consequence, potentially, of what we're seeing here," she said.

- Harmful autoantibodies. Not only is the immune system in men weaker, but in some severe cases of the coronavirus, it may hobble itself. A study of nearly 1,000 patients with life-threatening COVID-19, published in Science in September, found evidence of molecular self-sabotage. Immune system fighters were acting against the body's defenses, like rebellious castle guards splintering their own gates. This flaw was much more prevalent in men than women.

Specifically, the researchers detected what are called autoantibodies, molecules that bind and neutralize parts of the immune system. Those neutralizers disabled a subset of defender molecules known as type-1a interferon. Simply put, having autoantibodies led to more viral replication.

Ninety-five of 101 people with autoantibodies against interferon were male. "Somehow males are probably more prone to develop such autoantibodies, but we do not know why," said study author Petter Brodin, a pediatrician at Sweden's Karolinska Institute who studies the immune system.

Interferon molecules come in several types, so it's possible these patients could be treated with another flavor of interferon, Brodin said. But that may be difficult, he acknowledged, because interferons are most helpful early in the course of an infection, before the disease progresses to life-threatening stages.

The lack of killer T cells, coupled with neutralizing antibodies, is "like a double whammy," Iwasaki said, "that would then ultimately increase the viral load in these men."

What's unusual about this result is that most autoantibody immune disorders appear in women, as is the case with the chronic disease lupus.

Iwasaki's research is examining whether female immune systems may play a role in people with long-lasting COVID-19, nicknamed long-haulers.

"There are thousands of people suffering from chronic symptoms," which may be debilitating, Iwasaki said. Many long-haulers are young and the majority of them, though not all, are women.

- Men behaving differently.

Beyond these biological differences, it would be simplistic to ignore how gender's other aspects, such as behavior and social norms, may also influence the pandemic.

Broadly speaking, men may be less likely to be worried about COVID-19 than women, fitting the pattern that women generally treat health risks more seriously. Women took a more cautious approach to the disease, a recent poll found, expressing more concern they could return to workplaces safely. Women are also more likely to follow expert advice such as mask-wearing and social distancing, according to another study that included surveys and observations of pedestrians' behavior in New York, Connecticut and New Jersey.

Sarah Hawkes, a professor of global public health at University College London who, with her husband, co-directs Global Health 50/50, said that the image of men as risk-takers extends back hundreds of years to John Graunt, one of the first people to participate in the field now known as epidemiology.

After he reviewed England's death records, Graunt postulated in 1662 that "men, being more intemperate then women, die as much by reason of their Vices" - that is, male behavior was to blame. Hawkes argues that "350 years later," Graunt's point still stands. "It is undoubtedly a mixture of both biology and behavior" responsible for the health differences in men and women, she said.

The share of coronavirus deaths in women also rises with their share of the full-time workforce, according to a report by University of Oxford economist Renee Adams that used Global Health 50/50 data.

"The more you have women participating in the workforce, the smaller your sex difference becomes," Hawkes said. That lines up with gender inequalities - men are more likely to work in environments where they are exposed to air pollution and other harms, Hawkes said. When women start to enter those traditionally masculine spaces, she said, it "turns out, women can get as sick as men."

The gender disparities discovered in the response to COVID-19 have sparked a surge of interest in such differences more broadly. "Almost nobody, apart from the people working in the field, were interested in that difference between men and women in disease until February or March," when the first results showed that more men were dying, Mauvais-Jarvis said.

Even agencies at the forefront of public health, such as the CDC, were initially slow to reveal sex-disaggregated coronavirus data, Hawkes said. The U.K. public health surveillance system was similarly late. Hawkes took those delays as a sign of just how unimportant people considered this data, since it is so readily available: When people die, their death certificates state whether they were male, female or, in some places, nonbinary.

The CDC data finally made that information accessible in mid-April. The male-skewed patterns revealed in those deaths conform to what was seen in earlier outbreaks of Middle East respiratory syndrome (MERS) and severe acute respiratory syndrome (SARS), both within the family of coronaviruses. And it is in line with other viral responses. "We know that women develop much better antibody response to flu vaccines," Iwasaki said.

Some of those experts are hoping to capitalize on this moment to shine a spotlight on other gender differences in health. The coronavirus, after all, isn't the only problem to afflict men and women unequally - so, too, do cancer, asthma, heart disease and other common illnesses, as Mauvais-Jarvis noted in a recent paper in the Lancet.

"The kinds of differences that we're seeing and outcomes in COVID-19 are not unexpected. They're not exceptional," Hawkes said. If there's surprise, it only demonstrates the widespread underestimation of the differences in men and women that persist even among physicians, she said.

Mauvais-Jarvis referred to this faulty approach as "bikini medicine" - in which clinicians view female patients as interchangeable with male ones, except for the organs covered by swimwear.

The coronavirus has helped accelerate the trend away from that outdated view. The "one positive that's come out of the pandemic," Hawkes said, is the sudden realization that gendered social factors and biology "may have a relationship with your life expectancy, your experience with illness, your risk of illness. It has made that conversation a little bit more real."

View original post here:
Why is coronavirus killing more men than women? - theday.com

Read More...

Factor D: Is blocking this protein the key to stopping COVID-19 from damaging organs? – CTV News

Saturday, October 17th, 2020

TORONTO -- While scientists race to develop a safe and effective vaccine to prevent the spread of COVID-19, researchers at Johns Hopkins University have focused on preventing severe organ damage from patients own immune systems by inhibiting an important protein.

The team from the universitys school of medicine sought to better understand how SARS-CoV-2, the virus that causes COVID-19, attacks the body and causes severe inflammatory responses in certain individuals.

The studys senior author, Dr. Robert Brodsky, director of the hematology division at the Johns Hopkins University School of Medicine, explained that their research focused on an integral part of the immune system called the innate immune system or the complement system.

This is really our first defence against a lot of bacteria and viruses, he told CTVNews.ca during a telephone interview from Baltimore, Md. on Thursday.

The complement system enhances, or complements, the ability of antibodies and phagocytic cells to clear pathogens from the body. This system consists of more than 30 proteins, including two factor H and factor D that were of particular interest to the research team.

Factor H is a control protein that regulates the chemical signals that trigger inflammation and the immune system.

Its what allows the complement system to fight off foreign organisms, but not destroy host tissues, Brodsky explained.

Factor D is another protein in the complement system that is immediately upstream from factor H in the chain of immune events triggered by the virus.

During an infection of SARS-CoV-2, the famous spike proteins on the surface of the virus, which make it resemble a medieval mace, allow it to attach to healthy cells in the human body. In order to do this, the spikes latch on to heparan sulfate a large sugar molecule found on the surface of cells in the lungs, blood vessels, and smooth muscle of most organs.

Just binding to heparan sulfate, [the virus] probably couldnt get into the cell and start replicating. But without heparan sulfate, there wouldnt be enough of it to get to the ACE-2 receptor, he said.

There has been a lot of attention given to the role of the ACE-2 receptor protein (angiotensin-converting enzyme 2) and its role as an entry point for the coronavirus to infect a range of human cells.

However, Brodsky said the ACE-2 receptor isnt on all tissues, which is why his team focused on how the coronavirus binds to the heparan sulfate molecule instead.

Heparan sulfate is pretty much on every cell, just about every cell in the body, he said.

Returning to factor H, the researchers found that when the SARS-CoV-2 virus binds with the cells heparan sulfate sugar molecule, it occupies the site where the factor H protein would normally attach to protect that cell from the bodys immune response.

Without this protection, cells in the lungs, heart, kidneys and other organs can be destroyed by the defence mechanism nature intended to safeguard them, the researchers said.

To prevent the virus from occupying factor Hs spot on cells and leaving vital organs vulnerable to the bodys immune response, the academics attempted to stop that sequence of events from occurring at all by inhibiting factor D.

As previously mentioned, factor D is located directly upstream from factor H in the complement system. By blocking the function of factor D, the sequence of immune events triggered by the invading virus will also be stopped.

To simplify, Brodsky compared the complement systems immune response to a car in motion.

The viral spike proteins disable the biological brakes, factor H, enabling the gas pedal, factor D, to accelerate the immune system and cause cell, tissue and organ devastation. Inhibit factor D, and the brakes can be reapplied and the immune system reset, he explained.

In the lab, the research team used a small molecule in a complement-inhibiting drug to block factor D and the chain of events leading to the immune systems attack on the bodys healthy cells.

While the drug hasnt been approved by the U.S. Food and Drug Association (FDA) yet, Brodsky said its being tested in late-stage clinical trials. He said there are already a number of other complement-inhibiting drugs in the pipeline for other diseases, including age-related macular degeneration, which may have a use in the fight against COVID-19.

There are a number of these drugs that will be FDA-approved and in clinical practice within the next two years, Brodsky said. Perhaps one or more of these could be teamed with vaccines to help control the spread of COVID-19 and avoid future viral pandemics.

The researchers findings were recently published in the journal Blood.

Read the original here:
Factor D: Is blocking this protein the key to stopping COVID-19 from damaging organs? - CTV News

Read More...

Coronavirus reinfection cases: what we know so far and the vital missing clues – The Conversation UK

Saturday, October 17th, 2020

As President Trump claims that he is immune to COVID-19 and isolated reports emerge of reinfection, what is the truth about immunity to COVID-19?

To date, there have been six published cases of COVID-19 reinfection, with various other unverified accounts from around the world. Although this is a comparably small fraction of the millions of people known to have been infected, should we be concerned? To unpick this puzzle, we must first consider what we mean by immunity.

When we are infected with any pathogen, our immune system quickly responds to try to contain the threat and minimise any damage. Our first line of defence is from immune cells, known as innate cells. These cells are not usually enough to eliminate a threat, which is where having a more flexible adaptive immune response comes into play our lymphocytes.

Lymphocytes come in two main varieties: B lymphocytes, which make antibodies, and T lymphocytes, which include cells that directly kill the germy invaders.

As antibodies are readily measured in blood, they are often used to indicate a good adaptive immune response. However, over time, antibodies levels in our blood wane, but this doesnt necessarily mean protection is lost. We retain some lymphocytes that know how to deal with the threat our memory cells. Memory cells are remarkably long-lived, patrolling our body, ready to spring into action when needed.

Vaccines work by creating memory cells without the risk of a potentially fatal infection. In an ideal world, it would be relatively easy to create immunity, but its not always that straightforward.

Although our immune system has evolved to deal with a huge variety of pathogens, these germs have also evolved to hide from the immune system. This arms race means that some pathogens such as malaria or HIV are very tricky to deal with.

Infections that have spilled over from animals - zoonotic diseases - are also challenging for our immune system because they can be completely novel. The virus that causes COVID-19 is such a zoonotic disease, originating in bats.

COVID-19 is caused by a betacoronavirus. Several betacoronaviruses are already common in the human population most familiar as a cause of the common cold. Immunity to these cold-causing viruses isnt that robust but immunity to the more serious conditions, Mers and Sars, is more durable.

Data to date on COVID-19 shows that antibodies can be detected three months after infection, although, as with Sars and Mers, antibodies gradually decrease over time.

Of course, antibody levels are not the only indication of immunity and dont tell us about T lymphocytes or our memory cells. The virus causing COVID-19 is structurally similar to Sars, so perhaps we can be more optimistic about a more durable protective response time will tell. So how worried then should we be about reports of reinfection with COVID-19?

The handful of case reports on reinfection with COVID-19 dont necessarily mean that immunity is not occurring. Issues with testing could account for some reports because virus can be detected after infection and recovery. The tests look for viral RNA (the viruss genetic material), and viral RNA that cannot cause infection can be shed from the body even after the person has recovered.

Conversely, false-negative results happen when the sample used in testing contains insufficient viral material to be detected for example, because the virus is at a very low level in the body. Such apparent negative results may account for cases in which the interval between the first and second infection is short. It is hugely important, therefore, to use additional measures, such as viral sequencing and immune indicators.

Reinfection, even in immunity, can happen, but usually this would be mild or asymptomatic because the immune response protects against the worst effects. Consistent with this is that most verified cases of reinfection reported either no or mild symptoms. However, one of the latest verified cases of reinfection which happened just 48 days after the initial infection actually had a more severe response to reinfection.

What might account for the worse symptoms the second time round? One possibility is the patient did not mount a robust adaptive immune response first time round and that their initial infection was largely contained by the innate immune response (the first line of defence). One way to monitor this would be to assess the antibody response as the type of antibody detected can tell us something about the timing of infection. But unfortunately, antibody results were not analysed in the recent patients first infection.

Another explanation is that different viral strains caused the infections with a subsequent impact on immunity. Genetic sequencing did show differences in viral strains, but it isnt known if this equated to altered immune recognition. Many viruses share structural features, enabling immune responses to one virus to protect against a similar virus. This has been suggested to account for the lack of symptoms in young children who frequently get colds caused by betacoronaviruses.

However, a recent study, yet to be peer-reviewed, found that protection against cold-causing coronaviruses did not protect against COVID-19. In fact, antibodies recognising similar viruses can be dangerous accounting for the rare phenomenon of antibody-dependent enhancement of disease (ADE). ADE occurs when antibodies enhance viral infection of cells with potentially life-threatening consequences.

It should be emphasised, though, that antibodies are only one indicator of immunity and we have no data on either T lymphocytes or memory cells in these cases. What these cases emphasise is a need to standardised approaches in order to capture the critical information for robust evaluation of the threat of reinfection.

We are still learning about the immune response to COVID-19, and every piece of new data is helping us unpick the puzzle of this challenging virus. Our immune system is a powerful ally in the fight against infection, and only by unlocking it can we ultimately hope to defeat COVID-19.

See original here:
Coronavirus reinfection cases: what we know so far and the vital missing clues - The Conversation UK

Read More...

COVID-19 immunity? Ottawa researchers to test long-term potency of coronavirus immune response – Global News

Saturday, October 17th, 2020

Researchers in Ottawa are embarking on a 10-month study to answer critical questions about how individual immune system responses to the novel coronavirus differ and how soon after infection a patient might be at risk again.

The teams findings could have major implications for vaccine research and help to predict an individuals risk of developing serious complications related to COVID-19, but one of the studys lead researchers warns the findings wont lead to any ironclad declarations of COVID immunity among recovered patients.

A team of researchers with the University of Ottawa and The Ottawa Hospital will study COVID-19 antibody and T cell responses from 1,000 subjects over the next 10 months. In an infection, T cells target infected cells and help to stimulate B cells, which then produce antibodies to neutralize pathogens and label them for disruption.

Half of the study participants will be people who have tested positive for the novel coronavirus, while the other half will be a surveillance cohort of front-line workers and other people who would have a high risk of exposure to the virus but might not have been tested for infection.

Story continues below advertisement

The goal will be to test how long these subjects immune systems produce antibodies capable of neutralizing the pathogen after the initial infection.

Dr. Marc-Andr Langlois, professor with the University of Ottawas Faculty of Medicine, tells Global News the study idea was first proposed in the spring to answer an integral question in combating the novel coronavirus pandemic.

Since the very beginning of the epidemic, we were quite sure everyone who is infected will make antibodies, but how long will those antibodies last and how long will that protection last?

The question of COVID immunity has been in the spotlight in recent weeks, with U.S. President Donald Trump proclaiming to be immune to COVID-19 after testing positive and subsequently recovering from the virus.

[ Sign up for our Health IQ newsletter for the latest coronavirus updates ]

Health experts have said Trumps messaging, which has included assertions that others who tested positive for the coronavirus are also immune, are extremely dangerous. Recent examples of individuals twice testing positive for the virus are also throwing those claims into doubt.

Langlois says Trump is a complicated case because of the experimental treatment he was given, which saw him treated with external antibodies rather than just developing them on his own.

Story continues below advertisement

Typically, an infected individuals immune response will develop its own antibodies and T cells the immune systems one-two punch to combat the pathogen. T cells and B cells can then form a memory of sorts that recognizes familiar pathogens and triggers a stronger response the next time a similar virus enters the immune system.

Trending Stories

The basis of long-term immunity is having these sentinels that remain in your lymph nodes and your bone marrow so that if youre re-exposed to the pathogen, you will be able to produce a fresh lot of antibodies on your own. These will be produced by your own cells and these will protect you, Langlois explains.

In the case of Trump, those antibodies came from an outside source and neutralized the virus. It is unknown if he has any memory B cells or memory T cells, he says.

But even in a typical immune response scenario, which can include an internal response triggered by an external vaccine, memory cells tend to fade after a period of time.

Because of the natural waning immunity to these antigens, vaccinations often require booster shots to restimulate the immune response for the long-term.

One of the most integral takeaways from the upcoming research, then, will be establishing the window of time when a booster would be needed for anyone receiving the upcoming COVID-19 vaccines so that the immunization sticks.

Story continues below advertisement

The convalescent cohort those who have had lab-confirmed cases of the novel coronavirus will be monitored over the next 10 months for their levels of neutralizing antibodies to help determine when the post-recovery immunity typically fades.

The other 500 participants who were at high risk of exposure but did not get a positive test will be tracked for their own immune responses.

Researchers are betting that a portion of the group, maybe five to 10 per cent, might have been infected early on in the pandemic and shown no or mild symptoms, making their immune responses especially important for determining what gives an individual more effective protection against the virus.

Well be able to monitor and study how these immune system responses are different from person to person and try to find predictors of disease severity, Langlois says.

By analyzing blood samples for neutralizing antibodies from these two cohorts, Langlois says the studys findings could help determine a minimum threshold of protection that could then predict whether someones immune system is likely to keep them safe from infection or more serious complications related to COVID-19.

He cautions, however, that immune responses vary greatly from person to person, and that the study wont give a standardized timeframe of immunity after a coronavirus infection. At best, the study could provide probabilities of infection based on various individual predictors, such as genetic markers.

Story continues below advertisement

Well never know for sure if they can get reinfected or what the severity of that infection is, Langlois says.

It will never be a black and white scenario where we say, Heres your stamp youre protected.

The Ottawa-based team, which includes epidemiologists, clinicians, legal and ethics experts, hopes to publish findings from the study in a years time, but Langlois notes that some research updates will likely be published as they go, given the time-sensitive nature of the work.

The researchers are currently looking for more participants in their study.

2020 Global News, a division of Corus Entertainment Inc.

Originally posted here:
COVID-19 immunity? Ottawa researchers to test long-term potency of coronavirus immune response - Global News

Read More...

World food day: Healthy food habits to armor our immune system in the changing weather – The Financial Express

Saturday, October 17th, 2020

Key soldiers in the fight include vitamins like A, C, E, B6, D, and minerals like zinc, iron, and selenium that help maintain a strong immune system and they are also antioxidants. (Representational image: IE)

By Namit Tyagi

The Autumn season has just begun in the country and we all are starting to fall a little sick with the common symptoms of cold and cough. Most grown-ups face such common symptoms twice a year whereas in children it is observed to be around 5-6 times. Everytime the weather changes, the count of allergens in the air also spikes up to nearly 200 viruses. The most common virus is Human Rhinovirus (HRV) that causes 40% of all colds. Thus these are mild viruses and can be eliminated easily from our body by following few precautionary measures.

To keep your immune system strong this season, adapt certain dietary habits and enjoy the festive season without any hurdle:

Eat more citrus fruits and vegetables Citrus fruits are an amazing source of Vitamin-C. It strengthens our immunity system and keeps our skin smooth and elastic. Citrus fruits are also rich in Vitamin-B nutrients, copper, phosphorus, potassium and magnesium as well. For their antioxidants properties, add them in their mid-morning or evening snack in the form of either salad or juice. Infact, having an orange a day is sufficient enough to fulfill all our Vitamin-C requirements.

Make sure you eat enough protein Protein helps our body in infinite ways. From muscular development to improving digestion. It is an important compound required in blood oxygenation which is then carried in all over the body. Add protein in your every meal in an adequate amount to fulfill your protein requirements thus help your body produce antibodies to boost immunity. The sources of protein include lentils, egg whites, quinoa,soya, broccoli and other dairy & poultry products.

Dont overlook prebiotic foods Add prebiotic sources in your meal or smoothies. Prebiotics are found in foods such as onion, garlic, banana, and curd. They assist in maintaining a balanced gut microbiome, which is a vital player in how your immune system functions. Prebiotics work by increasing the population of good bacteria in the gut which in turn sparks the production of anti-inflammatory cytokines, which are tiny proteins that help the immune system function.

Get enough vitamins through your diet Key soldiers in the fight include vitamins like A, C, E, B6, D, and minerals like zinc, iron, and selenium that help maintain a strong immune system and they are also antioxidants. Some foods that are rich in these vitamins include carrots, sweet potatoes, bell peppers, strawberries, almonds, avocados, salmon, oysters, tuna, and lean chicken breast. Enjoy adding them to your regular meals, evening or morning salads and smoothies.

Add Herbs and spices in your diet Turmeric, black pepper, cinnamon, clove, Tulsi, Giloy, ashwagandha, Mulethi are ayurvedically known for boosting immunity, you can enjoy them as kadha or tea in the early morning or evening. You can add ashwagandha powder or tablet with milk at night or post-dinner to have sound sleep because sound sleep helps in boosting your immune health.

Thus, adding on a few basic ingredients from our kitchen in our dietary routine and swapping junk evening snacks with a bowl of fruits and sprouts could make a big difference in terms of health and energy levels in our body.

(The author is Co-Founder & Head Nutritionist, Neuherbs & Neusafe India. Views expressed are personal.)

Get live Stock Prices from BSE, NSE, US Market and latest NAV, portfolio of Mutual Funds, calculate your tax by Income Tax Calculator, know markets Top Gainers, Top Losers & Best Equity Funds. Like us on Facebook and follow us on Twitter.

Financial Express is now on Telegram. Click here to join our channel and stay updated with the latest Biz news and updates.

Read the rest here:
World food day: Healthy food habits to armor our immune system in the changing weather - The Financial Express

Read More...

Video: How to boost your immune system to guard against COVID and other illnesses – Genetic Literacy Project

Saturday, October 17th, 2020

Scientists have recently developed ways to measure your immune age. Fortunately, it turns out your immune age can go down as well as up. And there are some simple ways to turn back the clock on your immune system.

One studyin older adults showed that those who got 10,000 steps a day on average had neutrophils as good as a young adult.

Exercise also has benefits for your T cells. Before they are released onto active duty, T-cells mature in a little-known organ called the thymus gland in your chest. The thymus degenerates over time, resulting in a drop-off in the number of T cells.

Physical activity has a huge effect on the rate of this degeneration. A study found that amateur cyclists aged between 55 and 79 had youthful thymus glands and their T-cell counts were similar to those of much younger people.

Another key factor in your immune age is your gut bacteria. There is good evidence that poor gut health is a cause of premature ageing and that a healthy microbiome can reduce your immune age. Eating a healthy, varied diet rich in fibre, plant matter and fermented foods can help maintain a healthy community of gut microbes.

Your body has a highly evolved, intricate defence system thats effective at keeping you well, but only if you look after it.

Read the original post

Read the original:
Video: How to boost your immune system to guard against COVID and other illnesses - Genetic Literacy Project

Read More...

11 ways to stay healthy this fall and boost your immune system – TODAY

Saturday, October 17th, 2020

Fall has fallen into place. The days are getting shorter, temperatures are vacillating and the threat of a cold, the flu, seasonal allergies and COVID-19 are all about to mingle. It's a lot to contend with, but there are a number of simple things we can do to stay healthy this fall, say public health experts.

TODAY spoke with Lorna Thorpe, Ph.D., M.P.H., director of the division of epidemiology in the department of population health at NYU Langone Medical Center, and Dr. S. Patrick Kachur, M.P.H., a professor of population and family health at the Columbia University Medical Center, both in New York City, to find out what we can do to try to stack the odds in our favor. Here are their tips for boosting physical health, mental health and immunity throughout the autumn season.

Both experts emphasize that getting a flu shot this fall is paramount. One of the challenges is we really don't know what the risk of having the flu and COVID either back-to-back or at the same time is going to be, Kachur told TODAY. Even simple respiratory infections, like colds, could make you more susceptible to some secondary infections. Sometimes people get bacterial pneumonia after they have the flu or a cold, so preventing colds and flus is important for that reason as well. If you do have a flu shot and still get the flu, for example, Kachur said there is good evidence that suggests the severity and duration of the illness will be lessened.

The steps were already taking to protect ourselves from COVID-19, like diligently wearing masks in shared spaces and frequently washing and sanitizing our hands, will help protect us from other types of illness too. The mask works primarily by blocking the particles that we expel when we breathe, cough or speak, said Kachur. He added that wearing a mask in a public space, even in the lobby of your own building, can not only help keep you from infecting others, it may help protect you from infection as well, since the mask can reduce the number of viral particles you breathe in. There's a theory with many respiratory viruses and we're still understanding how it can be with COVID, but the fewer particles of virus that you inhale, the less likely you are to develop a severe illness if you do get it.

Many people have reported that theyve been imbibing more during the pandemic. And while a "quarantini" or two may help take the edge off some of your COVID-19-related stress, its not the healthiest way to cope. Drinking alcohol, especially excessive drinking, can weaken your immune system and lower your bodys ability to fight off infection, said Thorpe. This is an important time for us to not be using alcohol as a crutch and to be drinking in moderation, she said.

Numerous studies suggest that psychological stress can contribute to reducing immunity. The problem is, as Thorpe pointed out, people seem to be experiencing significantly more stress this year. We have seen, for a number of reasons, many Americans reporting that their mental health is worse off as a result of the pandemic, said Thorpe. Stress is really a factor that influences our physical health and our mental health. The steps that we can take to reduce that agitation, such as limiting intake of the news cycle, really is important. There are a number of self-care strategies that can help reduce stress. However, said Thorpe, if youre feeling depressed, its important to seek professional help.

Maintaining connections with the people who are important to you may be more important than you think. For one thing, it can help promote better emotional health, said Thorpe. She pointed out that theres a growing body of research that suggests connectedness can also play a role in improving health outcomes. It may not be easy to be in the room with as many people as we'd like to be, she said, (but) it makes many of us feel not only mentally healthier, but safer.

There are a lot of things to lose sleep over these days, but both experts pointed out that a good nights sleep is crucial to maintaining good health. Sleep helps your body regenerate itself and getting enough sleep is key to fighting off pathogens, they said. Scientifically, Kachur added, we know that immune function is improved in people who are well-rested. Adults should aim for at least seven hours of sleep a night, according to the Centers for Disease Control and Prevention (CDC).

Boosting your vitamin intake through the consumption of fresh fruits and vegetables is one very easy and tasty way to diversify the nutrients youre getting and help boost your immunity. Fall is a great time for vegetables, said Thorpe. She even suggested considering a plant-based diet, which, compared with the standard American diet, is not only healthier but better for our environment, she said.

Physical activity is a great way to boost immunity, get fit, reduce stress and stay heart-healthy, said Thorpe. It really promotes endorphins that improve mental health, can also induce weight loss if weight loss is necessary and maintain muscle mass for different people, she said. Adults should aim for at least 150 minutes of moderate intensity activity each week (ideally a mix of aerobic and strength-training activities), according to the CDC.

The ability to go outside for a bike ride or a hike this spring and summer had a tremendous impact on people, observed Thorpe. We have increasing and abundant evidence that spending time in nature is both good for the body and the mind, she said. If youre going to be exercising outdoors this fall, be sure to follow appropriate social distancing guidelines and consider wearing a mask to stay safe.

This essential vitamin helps you develop strong bones and plays a role in supporting immune function. More recently, it has been linked with better outcomes for people infected with COVID-19, though more research is necessary to better understand whether and how it may help. You can get vitamin D from certain foods, like fortified dairy products, juices and cereals, fatty fish like salmon, tuna and mackerel, and some mushrooms. Your body can also make vitamin D when it's exposed to sunlight. Vitamin D, though added in milk, is important in immunity, but a lot of us just don't get enough of it in our everyday diet, explained Kachur. He suggested taking a half-hour walk outside every day to get your dose of vitamin D from sunlight or trying a supplement, especially on long dark days. Just be sure to clear it with your primary care doctor before you start taking vitamin D supplements.

Theres promising research on the efficacy of B vitamins and zinc for supporting the immune system and helping to shorten the duration of a cold. However, Kachur noted that while it likely won't hurt to take them, the mechanism of how they may help remains unclear. If youre considering adding B vitamins or zinc to your supplements regimen, consult with your doctor to be sure they wont interact with any other medications you might be taking.

The threat of COVID-19 on top of our usual cold and flu season the pressure is on to be more vigilant about our health, but it's always a good idea to practice healthy habits. Even if you do get a cold or the flu, the healthier you are when it starts, the better the outcome is likely to be, said Kachur. If for that reason alone, lets all do our best to stay as healthy and happy as possible this autumn.

Read the original here:
11 ways to stay healthy this fall and boost your immune system - TODAY

Read More...

For How Long Will President Trump Be Immune to the Coronavirus? – The New York Times

Saturday, October 17th, 2020

After receiving a heavy infusion of monoclonal antibodies to treat his bout of Covid-19, President Trump has declared that he is immune to the virus that causes it and talked privately about wearing a Superman T-shirt under his dress shirt when he left the hospital.

Even as the president has exulted in his supposed imperviousness to the coronavirus that is resurging across parts of the country, he has delighted in portraying former Vice President Joseph R. Biden Jr. as vulnerable and cloistered, wearing masks every time you see him.

But even if the president were now immune to the coronavirus, he may not remain so, scientists warn. The presidents unique treatment may have prevented his body from making the antibodies necessary for long-term protection.

The monoclonal antibodies he received were produced by the drug company Regeneron and will wane in a matter of weeks, as the synthetic molecules are known to do. Without replenishment, this decline may leave Mr. Trump even more susceptible to the virus than most patients who have recovered from Covid-19, several experts warned.

Moreover, the steroid treatment the president received early in the course of his illness suppresses the bodys natural immune response, including its propensity to make antibodies of its own.

He may be not protected the second time around, especially because he didnt develop his own antibodies, said Akiko Iwasaki, an immunologist at Yale University.

Most people who are infected with the coronavirus produce antibodies to the virus that should protect them from a second infection. Its unclear how long this immunity lasts; based on research into other coronaviruses, immunity may persist for up to a year, experts have said.

Keep up with Election 2020

But Mr. Trumps case is unique.

He announced his diagnosis early on Oct. 2, and a test did not pick up any antibodies in his blood, according to a report released by his physician, Dr. Sean Conley.

The lack of antibodies that early in the course of illness is not unusual. It can take from 10 days to three weeks for powerful antibodies to surface.

If he had tested positive, then we would know for sure that he has his own antibodies, said Dr. Dan Barouch, a virologist at Beth Israel Deaconess Medical Center in Boston.

Since he was antibody-negative, it is less likely but not ruled out, he added. He could have been in the early stage of generating his own antibodies. (Dr. Barouch is an investigator for Regenerons trial of the cocktail for preventing coronavirus infections.)

On Oct. 2, Mr. Trump received eight grams of a cocktail of two monoclonal antibodies made by Regeneron. These antibodies are infused into people like those of Mr. Trumps age, sex and weight who may struggle to produce an immune response of their own.

A test on Oct. 5 confirmed the presence of the antibodies, according to Dr. Conley.

But Dr. Barouch noted that the antibodies detected in the bloodstream are not his antibodies. Theyre antibodies that were administered. Those antibodies will wane over time.

Oct. 16, 2020, 9:19 p.m. ET

The monoclonal antibodies may have quickly suppressed the level of virus in Mr. Trumps body. While this may have protected the president from severe symptoms, it may also have prevented his immune system from making its own antibodies.

If you get the antibodies early on, and you either prevent or rapidly treat infections, Dr. Barouch said, then you probably will actually inhibit the generation of your own bodys antibodies.

Mr. Trump was also treated with dexamethasone, a steroid that is known to suppress the immune system. And he received it much earlier in the course of his illness than usual.

That also may suppress a patients antibody response, said Kartik Chandran, a virologist at Albert Einstein College of Medicine in the Bronx.

Older people and men are already less likely to generate it, he added, referring to antibodies. You add dexamethasone to the mix and God knows.

Mr. Trump received a huge dose of the antibodies, but blood levels are expected to fall by half between 21 to 25 days from infusion. Values in this range are sufficient to support monthly dosing, according to information provided by Regeneron.

The White House did not respond to questions about whether Mr. Trump intends to take monthly doses of the cocktail.

Regeneron has said that it has 50,000 doses of the cocktail in hand, and that it would need to begin rationing the therapy if the drug were to be widely distributed.

In a clinical trial, the drug maker is evaluating whether people given the cocktail make their own antibodies, but has not yet completed the analysis, according to a spokeswoman.

Monoclonal antibodies are generally considered to be safe and effective, but Regenerons cocktail has not yet been rigorously tested in clinical trials. A trial of a monoclonal antibody made by Eli Lilly was paused on Tuesday because of a safety concern.

Mr. Trump has endorsed both treatments and repeatedly declared his immunity to the coronavirus.

Im immune I could come down and start kissing everybody, he said at a rally on Tuesday in Jonesboro, Pa. Ill kiss every guy. Man and woman. Look at that guy, how handsome he is. Ill kiss him. Not with a lot of enjoyment, but thats OK.

Originally posted here:
For How Long Will President Trump Be Immune to the Coronavirus? - The New York Times

Read More...

Vanderbilt researchers make counterintuitive discoveries about immune-like characteristics of cells, chemotherapys impact on tissue growth -…

Saturday, October 17th, 2020

Vanderbilt University researchers have reported the counterintuitive discovery that certain chemotherapeutic agents used to treat tumors can have the opposite effect of tissue overgrowth in normal, intact mammary glands, epidermis and hair follicles. The researchers also are the first to report the discovery of an innate immune signaling pathway in fibroblaststhe spindle-shaped cells responsible for wound healing and collagen productionthat causes cells to proliferate. Such signaling pathways previously were attributed only to immune cells.

The article describing the research, DNA Damage Promotes Epithelial Hyperplasia and Fate Mis-specification via Fibroblast Inflammasome Activation, was published in the journal Developmental Cell on Oct. 13.

The findings of this work, led by postdoctoral fellow Lindsey Seldin and Professor and Chair of the Department of Cell and Developmental Biology Ian Macara, have broad implications for diseases associated with the immune system like psoriasis, as well as cancer and stem cell research.

Understanding the functionality of stem cells and the way that their behavior is regulated has been a longstanding research interest for Seldin. Normal stem cells have an amazing ability to continuously divide to maintain tissue function without forming tumors, she explained. We wanted to understand what happens to these cells in their native environment when subjected to damage, and if the response was connected to a specific tissue.

By testing perturbations to the epidermis, mammary gland and hair follicles vis--vis mechanical damage or DNA damage through chemotherapeutic agents, the researchers saw a paradoxical response: Stem cells, which otherwise would divide slowly, instead divided rapidly, promoting tissue overgrowth.

When the tissues were subjected to DNA damage, their stem cells overly proliferated, giving rise to different cells than they normally would. This was a very perplexing result, said Seldin, the papers lead author. We were determined to figure out if this was a direct response by the stem cells themselves or by inductive signals within their environment. The key clue was that stem cells isolated from the body did not behave the same way as in intact tissuean indication that the response must be provoked from signals being sent to the stem cells from other surrounding cell types.

The investigators turned their attention to fibroblasts, the predominant component of the tissue microenvironment. When fibroblasts in the epidermis were removed, the stem cell responsiveness to DNA damage was diminished, indicating that they played an important role. RNA sequencing revealed that fibroblasts can signal by way of inflammasomescomplexes within cells that help tissues respond to stress by clearing damaged cells or pathogens, which also in this case caused stem cells to divide. This is an astounding discovery, said Macara. Inflammasome signaling has previously been attributed only to immune cells, but now it seems that fibroblasts can assume an immune-like nature.

Seldin intends to replicate this work in the mammary gland to determine whether fibroblasts initiate the same innate immune response as in the epidermis, and more broadly how fibroblasts contribute to the development of cancer and other diseases associated with the immune system.

This work was supported by NCI/NIH grants R35CA132898, F32CA213794 and T32CA119925, as well as American Cancer Society grant PF-18-007-01-CCG.

Follow this link:
Vanderbilt researchers make counterintuitive discoveries about immune-like characteristics of cells, chemotherapys impact on tissue growth -...

Read More...

Coronavirus Reinfections Are Real but Very, Very Rare – The New York Times

Saturday, October 17th, 2020

Reports of reinfection with the coronavirus evoke a nightmarish future: Repeat bouts of illness, impotent vaccines, unrelenting lockdowns a pandemic without an end.

A case study published on Monday, about a 25-year-old man in Nevada, has stoked those fears anew. The man, who was not named, became sicker the second time that he was infected with the virus, a pattern the immune system is supposed to prevent.

But these cases make the news precisely because they are rare, experts said: More than 38 million people worldwide have been infected with the coronavirus, and as of Monday, fewer than five of those cases have been confirmed by scientists to be reinfections.

Thats tiny its like a microliter-sized drop in the bucket, compared to the number of cases that have happened all over the world, said Angela Rasmussen, a virologist at Columbia University in New York.

In most cases, a second bout with the virus produced milder symptoms or none at all. But for at least three people, including one patient in Ecuador, the illness was more severe the second time around than during the first infection. An 89-year-old woman in the Netherlands died during her second illness.

Rare as these cases may be, they do indicate that reinfection is possible, said Akiko Iwasaki, an immunologist at Yale University, who wrote a commentary accompanying the Nevada case study, published in The Lancet Infectious Diseases.

Its important to note that there are people who do get reinfected, and in some of those cases you get worse disease, Dr. Iwasaki said. You still need to keep wearing masks and practice social distancing even if you have recovered once from this infection.

We asked experts what is known about reinfections with the coronavirus, and what the phenomenon means for vaccinations and the course of the pandemic.

First, the good news: Reinfection seems to be vanishingly rare.

Since the first confirmed case of reinfection, reported in Hong Kong on Aug. 24, there have been three published cases; reports of another 20 await scientific review.

But its impossible to know exactly how widespread the phenomenon is. To confirm a case of reinfection, scientists must look for significant differences in the genes of the two coronaviruses causing both illnesses.

In the United States, where testing was a rare resource much of this year, many people were not tested unless they were sick enough to be hospitalized. Even then, their samples were usually not preserved for genetic analysis, making it impossible to confirm suspected reinfections.

A vast majority of people who do get reinfected may go undetected. For example, the man in Hong Kong had no symptoms the second time, and his infection was discovered only because of routine screening at the airport.

There are a lot of people that are going to also have been exposed that arent having symptoms, that were never going to hear about, said Marion Pepper, an immunologist at the University of Washington in Seattle.

People whose second infections are more severe are more likely to be identified, because they return to the hospital. But those are likely to be even rarer, experts said.

If this was a very common event, we would have seen thousands of cases, Dr. Iwasaki said.

Reinfections can occur for any number of reasons: because the initial infection was too mild to produce an immune response, for example, or because the immune system was compromised by other health conditions. On occasion, a patient may be exposed to a large amount of virus that seeded an infection before the immune response could respond.

This variability is entirely expected, experts said, and has been observed in patients with diseases like measles and malaria.

Youll never have the distribution of anything with millions of people where you dont have some very severe rare cases happening at the fringe, said Dr. Michael Mina, a pediatric immunologist at the Harvard T.H. Chan School of Public Health.

At least two of the reinfected patients in Europe had compromised immune systems, for example, and the 89-year-old woman who died was receiving chemotherapy. In other reinfected patients, genetic factors or the lack of certain previous immune exposures may have blunted the bodys ability to fight off a second attack.

There are some people who just dont develop good immune responses to certain pathogens, said Florian Krammer, an immunologist at the Icahn School of Medicine at Mount Sinai. What is causing that? Were not sure, but its rare, usually.

In a vast majority of known infected patients, experts said, the immune system functions as it should against other pathogens.

There are a lot of different infections where you can get re-exposed to the virus, and we would probably not know because you dont have symptoms, Dr. Pepper said. And that might be an important part of boosting immunity.

When the body is exposed to an unfamiliar virus, its normal first to develop some immunity and then to increase that response with each additional exposure. This phenomenon is well known among children, but it is less often seen in adults because they rarely encounter new viruses, Dr. Mina said.

I think its important to recognize that reinfections are literally embedded in the evolution of our immune system, he added. We sometimes lose track of that with so many people talking about this who really havent studied the immune system.

For every confirmed case of reinfection, there are dozens of anecdotal reports of infected people who were sick and seemingly recovered but then became ill again weeks to months later.

Usually there are crucial data missing in those cases, like a confirmed lab diagnosis, or a virus sample that can be sequenced.

The question is always, Is it a real reinfection? Dr. Krammer said. Its very often very challenging to kind of get that kind of data.

A vast majority of these cases are unlikely to be true infections. More likely, these are people experiencing a resurgence of symptoms connected to the original infection. The virus may set off an inflammatory response that can flare up even weeks later and cause symptoms like fatigue and heart problems. In rare cases, some patients may develop a chronic low-grade infection with the virus that never quite goes away.

Even with viruses that can cause acute infections, like flu, Dr. Krammer said, you can have persistent infections if your immune system is sufficiently compromised.

Although these are not real reinfections, they are still worrying if they lead to renewed illness or hospitalization months after the initial infection, Dr. Rasmussen said. If theres recrudescence happening frequently, and people are getting severely ill the second time around, thats potentially its own problem, she said.

Reinfected people without symptoms may still transmit the virus to others. The patient in Hong Kong, for example, was isolated in a hospital even though he had no symptoms. But his viral load was high enough that he could have passed the virus to others.

Obviously, that person wasnt ill, so it bodes well for him, but it doesnt bode well for the community, Dr. Pepper said.

But to be sure of infectiousness, researchers may need to look for live virus. South Korean researchers investigated hundreds of reports of reinfection and were able to rule them out as real cases after failing to grow infectious virus from the samples.

Similar procedures would be needed to rule out the possibility of transmission in each patient, Dr. Rasmussen said, adding, I think thats the only way youd be able to get to the bottom of that.

Reports of reinfection have raised concerns about whether vaccines for the coronavirus will be effective and help communities achieve population immunity. The worry is that the immunity produced by vaccines will not be sufficient in preventing reinfections with the virus.

In reality, experts said, vaccines have a better chance at generating robust immunity than does natural infection with the virus.

For example, the coronavirus is particularly adept at dodging the bodys early immune alarms, buying valuable time to seed an infection. In some people, this lag eventually triggers a cascading immune overreaction that can be more harmful than the infection itself.

Vaccines are intended to unfurl an immune response without interference from the virus, and thus may avoid this inflammatory sequence. Vaccines can also be manipulated to enhance immune memory, in that way producing more lasting, more protective responses.

Vaccine trials are designed to look for an absence of disease, rather than of infection, and its unclear whether vaccines can suppress virus levels enough to prevent transmission to others.

Still, vaccine-induced immunity should perform better than natural immunity, Dr. Rasmussen said, adding, Im optimistic.

Originally posted here:
Coronavirus Reinfections Are Real but Very, Very Rare - The New York Times

Read More...

Mild to severe: Immune system holds clues to virus reaction – ABC News

Wednesday, September 30th, 2020

One of COVID-19's scariest mysteries is why some people are mildly ill or have no symptoms and others rapidly die and scientists are starting to unravel why.

An international team of researchers found that in some people with severe COVID-19, the body goes rogue and attacks one of its own key immune defenses instead of fighting the coronavirus. Most were men, helping to explain why the virus is hitting men harder than women.

And separate research suggests that children fare better than adults thanks to robust first responder immune cells that wane with age.

They're the latest in a list of studies uncovering multiple features of the immune system's intricate cascade that can tip the scales between a good or bad outcome. Next up: Figuring out if all these new clues might offer much-needed ways to intervene.

We have the knowledge and capability of really boosting many aspects of the immune system. But we need to not use the sledge hammer, cautioned Dr. Betsy Herold of New York's Albert Einstein College of Medicine, who co-authored the child study.

Adding to the complexity, people's wildly varying reactions also reflect other factors, such as how healthy they were to begin with and how much of the virus the dose" they were exposed to.

Infection and what happens after infection is a very dynamic thing, said Alessandro Sette, a researcher at the La Jolla Institute for Immunology in San Diego, who is studying yet another piece of the immune response.

IMMUNE PRIMER

There are two main arms of the immune system. Innate immunity is the bodys first line of defense. As soon as the body detects a foreign intruder, key molecules, such as interferons and inflammation-causing cytokines, launch a wide-ranging attack.

Innate immune cells also alert the slower-acting adaptive arm of the immune system, the germ-specific sharpshooters, to gear up. B cells start producing virus-fighting antibodies, the proteins getting so much attention in the vaccine hunt.

But antibodies aren't the whole story. Adaptive immunity's many other ingredients include killer T cells that destroy virus-infected cells and memory T and B cells that remember an infection so they spring into action quicker if they encounter that germ again.

A MISSING PIECE

Usually when a virus invades a cell, proteins called Type I interferons spring into action, defending the cell by interfering with viral growth. But new research shows those crucial molecules were essentially absent in a subset of people with severe COVID-19.

An international project uncovered two reasons. In blood from nearly 1,000 severe COVID-19 patients, researchers found 1 in 10 had what are called auto-antibodies antibodies that mistakenly attack those needed virus fighters. Especially surprising, autoimmune disorders tend to be more common in women but 95% of these COVID-19 patients were men.

The researchers didn't find the damaging molecules in patients with mild or asymptomatic COVID-19.

In another 660 severely ill patients, the same team found 3.5% had gene mutations that didn't produce Type I interferons.

Each of those silent vulnerabilities was enough to tip the balance in favor of the virus early on, said Dr. Jean-Laurent Casanova, an infectious disease geneticist at Rockefeller University in New York, who co-leads the COVID Human Genetic Effort.

Certain interferons are used as medicines and are under study as a possible COVID-19 treatment; the auto-antibody discovery adds another factor to consider.

KIDS' IMMUNITY REVS FAST

It's not clear why children appear less at risk from COVID-19. But occasionally they're sick enough for hospitalization, giving Herold's team the opportunity to compare 60 adults and 65 children and teens at New Yorks Montefiore Health System.

The children produced much higher levels of certain cytokines that are among the innate immune system's first responders. When the immune system's next stage kicked in, both adults and children made antibodies targeting the coronavirus. Here's the rub: The adults' adaptive immune response was more the type that can trigger an inflammatory overreaction.

The findings suggest kids' early robust reaction lets their immune system get ahead of the virus, making an overreaction less likely "and that's protecting them, Herold said.

ANY PREEXISTING IMMUNITY?

The coronavirus that causes COVID-19 is new to humans. But Sette's team studied blood samples that were stored in freezers before the pandemic and found some harbored memory T cells that recognized a tiny portion of the new virus in laboratory tests.

You can actually tell that this is an experienced T cell. This has seen combat before, Sette said. Researchers in Germany, Britain and other countries have made similar findings.

The new coronavirus has cousins that cause as many as 30% of common colds, so researchers believe those T cells could be remnants from past colds.

But despite the speculation, we don't know yet that having those T cells makes any difference in who gets seriously sick with COVID-19, noted Rory de Vries, co-author of a study in the Netherlands that also found such T cells in old blood.

All these findings beg for a deeper understanding of the myriad ways some people can be more susceptible than others.

We need to look quite broadly and not jump into premature conclusions about any one particular facet of the immune system, said Stanford University immunologist Bali Pulendran. He also has found some innate immune cells in a state of hibernation in seriously ill adults and next is looking for differences before and after people get sick.

But, it's not just all about the immune system, cautioned Dr. Anita McElroy, a viral immunity expert at the University of Pittsburgh Medical Center whos closely watching the research. A way to tell in advance who's most at risk? Were a long, long way from that.

The Associated Press Health and Science Department receives support from the Howard Hughes Medical Institutes Department of Science Education. The AP is solely responsible for all content.

Go here to read the rest:
Mild to severe: Immune system holds clues to virus reaction - ABC News

Read More...

The immune system: How to boost it and lower your immune age – New Scientist News

Wednesday, September 30th, 2020

Your immune system stands between you and deadly infections. But as you get older so does your immune age, making you more susceptible to disease. Fortunately, we are discovering plenty of things you can do to turn back the clock and stay healthy. In this episode of our video series Science with Sam, find out how your immune system works and how you can give it a boost.

Tune in every week toyoutube.com/newscientistfor a new episode, or check back tonewscientist.com

One of the most important things standing between you and a deadly infection is your immune system the intricate, biological defence mechanism that protects your body from harmful invaders. And theres a lot we can do to give our immune system a helping hand.

Your immune system is made up of two divisions: the innate immune system and the adaptive immune system, each with its own battalion of specialist cells and defensive weapons.

Advertisement

The innate immune system is the first line of defence. Its made up of cells like the scary-sounding macrophage, and the less scary-sounding neutrophil. These general-purpose guards patrol the bloodstream on the lookout for anything that shouldnt be there. When they detect an intruder, they neutralise the threat by engulfing it like Pac-Man, spraying it with deadly chemicals or suicidally expelling their DNA and throwing it around the invader like a net.

Then theres the adaptive immune system, which you can think of as the immune systems special forces, elite agents trained to fight specific pathogens. Unlike the innate system, which can attack any invading cell or virus, these cells are only effective against one enemy, and they must be trained to fight them first.

B cells fight bacteria and viruses by making Y-shaped proteins called antibodies that neutralise an invader or tag it for attack by other parts of the immune system.

Then there are T cells. These coordinate and carry out attacks on infected cells. Helper T Cells call in reinforcements by sending out chemical messages known as cytokines. Killer T-Cells are the front line soldiers, trained, as the name suggests, to destroy the enemy.

When we encounter a disease for the first time, it takes a while for the adaptive immune system to learn how to fight it. But once its up and running, it creates a memory, allowing a fast and brutal response to future infections often neutralising it before you even notice. This is the premise of vaccines and the reason why you only get diseases like chicken pox once.

If you want to know more about vaccines, theres a video all about them, just hit the link at the end of this video. Better yet, subscribe to New Scientist today and get 20 per cent off if you enter the code SAM20 at checkout.

Your immune system works so well that, most of the time, you wont even notice it. But it weakens as you get older, making you more susceptible to infection. Thats a key reason why people over the age of 70 are most vulnerable to diseases like covid-19, or even the flu.

This decline happens to all of us, but it can be accelerated by lifestyle factors like smoking and inactivity. Obesity is also linked to a faster decline in immune potency.

All of which means that, although the strength of your immune system is linked to your age, a 40-year-old can have the immune system of a 60-year-old. Or on the flipside, a healthy 60-year-old may have the immune system of a 40-year-old.

Scientists have recently developed ways to measure your immune age. Fortunately, it turns out your immune age can go down as well as up. And there are some simple ways to turn back the clock on your immune system.

As we get older, some of our immune cells start to misbehave. Take neutrophils, those early responder cells. As they age, they get worse at hunting down intruders, blundering through your tissues, causing damage.

The root of the problem is an overactive enzyme involved in their sense of direction. Dialling down that enzyme rejuvenates the neutrophils so they know where theyre going. And theres a simple, drug-free way to do it: exercise.

One study in older adults showed that those who got 10,000 steps a day on average had neutrophils as good as a young adult.

Exercise also has benefits for your T cells. Before they are released onto active duty, T-cells mature in a little-known organ called the thymus gland in your chest. The thymus degenerates over time, resulting in a drop-off in the number of T cells.

Physical activity has a huge effect on the rate of this degeneration. A study found that amateur cyclists aged between 55 and 79 had youthful thymus glands and their T-cell counts were similar to those of much younger people.

Another key factor in your immune age is your gut bacteria. There is good evidence that poor gut health is a cause of premature ageing and that a healthy microbiome can reduce your immune age. Eating a healthy, varied diet rich in fibre, plant matter and fermented foods can help maintain a healthy community of gut microbes.

Your body has a highly evolved, intricate defence system thats effective at keeping you well, but only if you look after it.

I dont know about you but Ive been a bit less active of late, so Im considering this something of a wake-up call.

Looking after your immune system is a no-brainer, and its as easy as a walk in the park.

More on these topics:

Read more:
The immune system: How to boost it and lower your immune age - New Scientist News

Read More...

Page 16«..10..15161718..3040..»


2025 © StemCell Therapy is proudly powered by WordPress
Entries (RSS) Comments (RSS) | Violinesth by Patrick